236 related articles for article (PubMed ID: 7486406)
21. Effects of R and S enantiomers and a racemic mixture of carprofen on the production and release of proteoglycan and prostaglandin E2 from equine chondrocytes and cartilage explants.
Armstrong S; Lees P
Am J Vet Res; 1999 Jan; 60(1):98-104. PubMed ID: 9918155
[TBL] [Abstract][Full Text] [Related]
22. Retinoic acid-induced type II collagen degradation does not correlate with matrix metalloproteinase activity in cartilage explant cultures.
Price JS; Wang-Weigand S; Bohne R; Kozaci LD; Hollander AP
Arthritis Rheum; 1999 Jan; 42(1):137-47. PubMed ID: 9920024
[TBL] [Abstract][Full Text] [Related]
23. Comparative and combined effects of interleukin 6, interleukin 1 beta, and tumor necrosis factor alpha on proteoglycan metabolism of human articular chondrocytes cultured in agarose.
Malfait AM; Verbruggen G; Veys EM; Lambert J; De Ridder L; Cornelissen M
J Rheumatol; 1994 Feb; 21(2):314-20. PubMed ID: 8182643
[TBL] [Abstract][Full Text] [Related]
24. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures.
Stefanovic-Racic M; Morales TI; Taskiran D; McIntyre LA; Evans CH
J Immunol; 1996 Feb; 156(3):1213-20. PubMed ID: 8558000
[TBL] [Abstract][Full Text] [Related]
25. Effect of methylprednisolone acetate on proteoglycan and collagen metabolism of articular cartilage explants.
Todhunter RJ; Fubini SL; Wootton JA; Lust G
J Rheumatol; 1996 Jul; 23(7):1207-13. PubMed ID: 8823694
[TBL] [Abstract][Full Text] [Related]
26. Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant cultures.
Kozaci LD; Buttle DJ; Hollander AP
Arthritis Rheum; 1997 Jan; 40(1):164-74. PubMed ID: 9008612
[TBL] [Abstract][Full Text] [Related]
27. Oncostatin M (OSM) stimulates resorption and inhibits synthesis of proteoglycan in porcine articular cartilage explants.
Hui W; Bell M; Carroll G
Cytokine; 1996 Jun; 8(6):495-500. PubMed ID: 8818547
[TBL] [Abstract][Full Text] [Related]
28. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
29. Investigation of the role of metalloproteinases in recombinant human interleukin-1 beta-induced degradation of rat femoral head cartilage.
Seed MP; Thomson TA; Gardner CR
Drugs Exp Clin Res; 1991; 17(7):355-61. PubMed ID: 1794302
[TBL] [Abstract][Full Text] [Related]
30. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium.
Okada Y; Shinmei M; Tanaka O; Naka K; Kimura A; Nakanishi I; Bayliss MT; Iwata K; Nagase H
Lab Invest; 1992 Jun; 66(6):680-90. PubMed ID: 1602738
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the levels of human trabecular matrix metalloproteinases and inhibitor by interleukin-1 and dexamethasone.
Samples JR; Alexander JP; Acott TS
Invest Ophthalmol Vis Sci; 1993 Nov; 34(12):3386-95. PubMed ID: 8225873
[TBL] [Abstract][Full Text] [Related]
32. The role of cytokines in chondrocyte mediated cartilage degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y
J Rheumatol Suppl; 1989 Aug; 18():32-4. PubMed ID: 2810294
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of bFGF and IGF-I on matrix metabolism in calf and adult bovine cartilage explants.
Sah RL; Chen AC; Grodzinsky AJ; Trippel SB
Arch Biochem Biophys; 1994 Jan; 308(1):137-47. PubMed ID: 8311446
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of cartilage degradation and changes in physical properties induced by IL-1beta and retinoic acid using matrix metalloproteinase inhibitors.
Bonassar LJ; Sandy JD; Lark MW; Plaas AH; Frank EH; Grodzinsky AJ
Arch Biochem Biophys; 1997 Aug; 344(2):404-12. PubMed ID: 9264555
[TBL] [Abstract][Full Text] [Related]
35. Bafilomycin A1 inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis.
Yocum SA; Lopresti-Morrow LL; Gabel CA; Milici AJ; Mitchell PG
Arch Biochem Biophys; 1995 Feb; 316(2):827-35. PubMed ID: 7864640
[TBL] [Abstract][Full Text] [Related]
36. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the involvement of interleukin 1 in human osteoarthritic cartilage degradation: protective effect of NSAID.
Pelletier JP; Martel-Pelletier J
J Rheumatol Suppl; 1989 Aug; 18():19-27. PubMed ID: 2553967
[TBL] [Abstract][Full Text] [Related]
38. Effect of glucosamine on interleukin-1-conditioned articular cartilage.
Fenton JI; Chlebek-Brown KA; Caron JP; Orth MW
Equine Vet J Suppl; 2002 Sep; (34):219-23. PubMed ID: 12405690
[TBL] [Abstract][Full Text] [Related]
39. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
40. The role of mononuclear cell products as modulators of cartilage degradation.
Mort JS; Campbell IK; Guttman A; Golds EE; Roughley PJ
J Rheumatol; 1987 May; 14 Spec No():86-7. PubMed ID: 3305942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
